{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:38:04Z","timestamp":1794490684783,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05059-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:56:00Z","timestamp":1759229760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The efficacy and safety of herbal medicines for glycaemic control and insulin resistance in individuals with type 2 diabetes: an umbrella review"],"prefix":"10.1186","volume":"25","author":[{"given":"Ethan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Maunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhiti","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Cave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allana","family":"O\u2019Fee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"10467","key":"5059_CR1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"B Zhou","year":"2024","unstructured":"Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(24)02317-1.","journal-title":"Lancet"},{"key":"5059_CR2","doi-asserted-by":"publisher","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17). https:\/\/doi.org\/10.3390\/ijms21176275.","DOI":"10.3390\/ijms21176275"},{"issue":"16 Suppl","key":"5059_CR3","first-page":"S441","volume":"8","author":"T Killilea","year":"2002","unstructured":"Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care. 2002;8(16 Suppl):S441\u20139.","journal-title":"Am J Manag Care"},{"key":"5059_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne). 2017;8:6. https:\/\/doi.org\/10.3389\/fendo.2017.00006.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5059_CR5","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.19082\/1832","volume":"8","author":"W Kooti","year":"2016","unstructured":"Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: a systematic review. Electron Phys. 2016;8(1):1832\u201342. https:\/\/doi.org\/10.19082\/1832.","journal-title":"Electron Phys"},{"key":"5059_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ijbiomac.2018.10.072","volume":"121","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Bai L, Zhou Y, Tong R, Zeng M, Li X, et al. Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances. Int J Biol Macromol. 2019;121:1240\u201353. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.10.072.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"5059_CR7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00228-021-03097-x","volume":"77","author":"AS Alzahrani","year":"2021","unstructured":"Alzahrani AS, Price MJ, Greenfield SM, Paudyal V. Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77(9):1259\u201374. https:\/\/doi.org\/10.1007\/s00228-021-03097-x.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5059_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12906-018-2147-3","volume":"18","author":"AB Mekuria","year":"2018","unstructured":"Mekuria AB, Belachew SA, Tegegn HG, Ali DS, Netere AK, Lemlemu E, et al. Prevalence and correlates of herbal medicine use among type 2 diabetic patients in Teaching Hospital in Ethiopia: a cross-sectional study. BMC Complement Altern Med. 2018;18(1):85. https:\/\/doi.org\/10.1186\/s12906-018-2147-3.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"5059_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-020-2854-4","volume":"20","author":"A Alqathama","year":"2020","unstructured":"Alqathama A, Alluhiabi G, Baghdadi H, Aljahani L, Khan O, Jabal S, et al. Herbal medicine from the perspective of type II diabetic patients and physicians: what is the relationship? BMC Complement Med Ther. 2020;20(1):1\u201312. https:\/\/doi.org\/10.1186\/s12906-020-2854-4.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"5059_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12906-018-2160-6","volume":"18","author":"AN Welz","year":"2018","unstructured":"Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):92. https:\/\/doi.org\/10.1186\/s12906-018-2160-6.","journal-title":"BMC Complement Altern Med"},{"key":"5059_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"M Ekor","year":"2014","unstructured":"Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. https:\/\/doi.org\/10.3389\/fphar.2013.00177.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5059_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/FAD.0000000000000058","volume":"331","author":"PA Routledge","year":"2021","unstructured":"Routledge PA, Bracchi R. Adverse drug reactions to herbal medicines. Adverse Drug React Bull. 2021;331(1):1283\u20136. https:\/\/doi.org\/10.1097\/FAD.0000000000000058.","journal-title":"Adverse Drug React Bull"},{"key":"5059_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13098-017-0254-9","volume":"9","author":"RC Gupta","year":"2017","unstructured":"Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr. 2017;9:59. https:\/\/doi.org\/10.1186\/s13098-017-0254-9.","journal-title":"Diabetol Metab Syndr"},{"key":"5059_CR14","doi-asserted-by":"publisher","first-page":"777561","DOI":"10.3389\/fphar.2021.777561","volume":"12","author":"ML Willcox","year":"2021","unstructured":"Willcox ML, Elugbaju C, Al-Anbaki M, Lown M, Graz B. Effectiveness of medicinal plants for glycaemic control in type 2 diabetes: an overview of meta-analyses of clinical trials. Front Pharmacol. 2021;12:777561. https:\/\/doi.org\/10.3389\/fphar.2021.777561.","journal-title":"Front Pharmacol"},{"key":"5059_CR15","doi-asserted-by":"publisher","first-page":"001","DOI":"10.29328\/journal.hodms.1001001","volume":"1","author":"AM Carella","year":"2017","unstructured":"Carella AM, Marinelli T, Melfitano A, Di Pumpo M, M C. Hypoglycemia by ginseng in type 2 diabetic patient: case report. New Insights Obes Gene Beyond. 2017;1:001\u20136. https:\/\/doi.org\/10.29328\/journal.hodms.1001001.","journal-title":"New Insights Obes Gene Beyond."},{"key":"5059_CR16","doi-asserted-by":"publisher","first-page":"1069268","DOI":"10.3389\/fphar.2023.1069268","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Y, Xu Q, Ma J, Li X, Tian Y, et al. Ginseng and health outcomes: an umbrella review. Front Pharmacol. 2023;14:1069268. https:\/\/doi.org\/10.3389\/fphar.2023.1069268.","journal-title":"Front Pharmacol"},{"key":"5059_CR17","unstructured":"World Health Organization. WHO traditional medicine strategy: 2014\u20132023 Geneva: 2013 updated 2013. https:\/\/www.who.int\/publications\/i\/item\/9789241506096. Accessed: 14 May."},{"issue":"2","key":"5059_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.clnu.2019.02.006","volume":"39","author":"E Rezaeiamiri","year":"2020","unstructured":"Rezaeiamiri E, Bahramsoltani R, Rahimi R. Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: a review of clinical trials. Clin Nutr. 2020;39(2):331\u201342. https:\/\/doi.org\/10.1016\/j.clnu.2019.02.006.","journal-title":"Clin Nutr"},{"key":"5059_CR19","unstructured":"National Health and Medical Research Council. Appendix F: Levels of evidence and recommendation grading Melbourne: 2009. https:\/\/www.nhmrc.gov.au\/sites\/default\/files\/images\/appendix-f-levels-of-evidence.pdf. Accessed: 15 May."},{"issue":"1","key":"5059_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12997\/jla.2023.12.1.3","volume":"12","author":"GJ Choi","year":"2023","unstructured":"Choi GJ, Kang H. Introduction to umbrella reviews as a useful evidence-based practice. J Lipid Atheroscler. 2023;12(1):3\u201311. https:\/\/doi.org\/10.12997\/jla.2023.12.1.3.","journal-title":"J Lipid Atheroscler."},{"key":"5059_CR21","doi-asserted-by":"publisher","first-page":"e070849","DOI":"10.1136\/bmj-2022-070849","volume":"378","author":"M Gates","year":"2022","unstructured":"Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849. https:\/\/doi.org\/10.1136\/bmj-2022-070849.","journal-title":"BMJ"},{"key":"5059_CR22","unstructured":"Nutrient supplements for Type 2 Diabetes: an umbrella review. OSF. 2022. https:\/\/osf.io\/pt94r. Cited 15 May."},{"key":"5059_CR23","unstructured":"Therapeutic Goods Regulations 1990. Australian Government; 2024."},{"key":"5059_CR24","doi-asserted-by":"publisher","unstructured":"Fong C, Alesi S, Mousa A, Moran LJ, Deed G, Grant S, et al. Efficacy and safety of nutrient supplements for glycaemic control and insulin resistance in type 2 diabetes: an umbrella review and hierarchical evidence synthesis. Nutrients. 2022;14(11). https:\/\/doi.org\/10.3390\/nu14112295.","DOI":"10.3390\/nu14112295"},{"key":"5059_CR25","doi-asserted-by":"publisher","first-page":"1357914","DOI":"10.3389\/fmed.2024.1357914","volume":"11","author":"J Lin","year":"2024","unstructured":"Lin J, Liu J, O\u2019Fee A, Pandey C, Benna-Doyle S, Maunder A, et al. The effectiveness and safety of lifestyle medicine and integrative therapies in inflammatory arthritis: an umbrella review using a hierarchical evidence gathering approach. Front Med (Lausanne). 2024;11:1357914. https:\/\/doi.org\/10.3389\/fmed.2024.1357914.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"5059_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","volume":"67","author":"D Pieper","year":"2014","unstructured":"Pieper D, Antoine SL, Mathes T, Neugebauer EA, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67(4):368\u201375. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.11.007.","journal-title":"J Clin Epidemiol"},{"key":"5059_CR27","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"key":"5059_CR28","unstructured":"BMJ Best Practice. What is GRADE? https:\/\/bestpractice.bmj.com\/info\/us\/toolkit\/learn-ebm\/what-is-grade\/. Accessed: 15 May."},{"issue":"20","key":"5059_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijms232012111","volume":"23","author":"MF Mahomoodally","year":"2022","unstructured":"Mahomoodally MF, Aumeeruddy MZ, Legoabe LJ, Montesano D, Zengin G. Nigella sativa L. and its active compound thymoquinone in the clinical management of diabetes: a systematic review. Int J Mol Sci. 2022;23(20):11. https:\/\/doi.org\/10.3390\/ijms232012111.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5059_CR30","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/10408398.2018.1430019","volume":"59","author":"DMUP Rocha","year":"2019","unstructured":"Rocha DMUP, Caldas APS, da Silva BP, Hermsdorff HHM, Alfenas RdCG. Effects of blueberry and cranberry consumption on type 2 diabetes glycemic control: a systematic review. Crit Rev Food Sci Nutr. 2019;59(11):1816\u201328. https:\/\/doi.org\/10.1080\/10408398.2018.1430019.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5059_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jep.2018.10.033","volume":"231","author":"EL Peter","year":"2019","unstructured":"Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, et al. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. J Ethnopharmacol. 2019;231:311\u201324. https:\/\/doi.org\/10.1016\/j.jep.2018.10.033.","journal-title":"J Ethnopharmacol"},{"issue":"21","key":"5059_CR32","doi-asserted-by":"publisher","first-page":"e19702","DOI":"10.1097\/MD.0000000000019702","volume":"99","author":"C Piao","year":"2020","unstructured":"Piao C, Zhang Q, Jin, Shao M, Bi C, Wang L, et al. Treatment of type 2 diabetes with Tianqi Jiangtang Capsule: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020;99(21):e19702. https:\/\/doi.org\/10.1097\/MD.0000000000019702.","journal-title":"Medicine (Baltimore)"},{"key":"5059_CR33","doi-asserted-by":"publisher","unstructured":"Robertson NU, Schoonees A, Brand A, Visser J. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database Syst Rev. 2020 (9). https:\/\/doi.org\/10.1002\/14651858.CD008294.pub5","DOI":"10.1002\/14651858.CD008294.pub5"},{"key":"5059_CR34","doi-asserted-by":"publisher","first-page":"102414","DOI":"10.1016\/j.ctim.2020.102414","volume":"51","author":"Z Safari","year":"2020","unstructured":"Safari Z, Farrokhzad A, Ghavami A, Fadel A, Hadi A, Rafiee S, et al. The effect of barberry (Berberis vulgaris L.) on glycemic indices: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;51:102414. https:\/\/doi.org\/10.1016\/j.ctim.2020.102414.","journal-title":"Complement Ther Med"},{"issue":"8","key":"5059_CR35","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/dom.13760","volume":"21","author":"J Tian","year":"2019","unstructured":"Tian J, Jin, Bao Q, Ding Q, Zhang H, Gao Z, et al. Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2019;21(8):1801\u201316. https:\/\/doi.org\/10.1111\/dom.13760.","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"5059_CR36","doi-asserted-by":"publisher","first-page":"e14130","DOI":"10.1111\/jfbc.14130","volume":"46","author":"X Zhang","year":"2022","unstructured":"Zhang X, Chen X, Tang Y, Guan X, Deng J, Fan J. Effects of medical plants from Zingiberaceae family on cardiovascular risk factors of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Food Biochem. 2022;46(7):e14130. https:\/\/doi.org\/10.1111\/jfbc.14130.","journal-title":"J Food Biochem"},{"key":"5059_CR37","doi-asserted-by":"publisher","first-page":"1018450","DOI":"10.3389\/fendo.2022.1018450","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liu L, Liu J. Treatment of type 2 diabetes mellitus using the traditional Chinese medicine Jinlida as an add-on medication: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2022;13:1018450. https:\/\/doi.org\/10.3389\/fendo.2022.1018450.","journal-title":"Front Endocrinol"},{"key":"5059_CR38","doi-asserted-by":"publisher","first-page":"153455","DOI":"10.1016\/j.phymed.2020.153455","volume":"88","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Ding Q, Wei Y, Gou X, Tian J, Li M, et al. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis. Phytomedicine. 2021;88:153455. https:\/\/doi.org\/10.1016\/j.phymed.2020.153455.","journal-title":"Phytomedicine"},{"key":"5059_CR39","doi-asserted-by":"publisher","unstructured":"Salleh NH, Zulkipli IN, Mohd Yasin H, Ja'afar F, Ahmad N, Wan Ahmad WAN, et al. Systematic review of medicinal plants used for treatment of diabetes in human clinical trials: an ASEAN perspective. Evid Based Complement Alternat Med. 2021:1\u201310. https:\/\/doi.org\/10.1155\/2021\/5570939.","DOI":"10.1155\/2021\/5570939"},{"issue":"2","key":"5059_CR40","first-page":"643","volume":"11","author":"F Shidfar","year":"2012","unstructured":"Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, Hajhassani G. The effects of berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iran J Pharm Res. 2012;11(2):643\u201352.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"5059_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000346607","volume":"20","author":"S Kianbakht","year":"2013","unstructured":"Kianbakht S, Abasi B, Dabaghian FH. Anti-hyperglycemic effect of Vaccinium arctostaphylos in type 2 diabetic patients: a randomized controlled trial. Forsch Komplementmed. 2013;20(1):17\u201322. https:\/\/doi.org\/10.1159\/000346607.","journal-title":"Forsch Komplementmed"},{"issue":"5","key":"5059_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/1753-0407.12342","volume":"8","author":"M Mirfeizi","year":"2016","unstructured":"Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: a triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016;8(5):647\u201356. https:\/\/doi.org\/10.1111\/1753-0407.12342.","journal-title":"J Diabetes"},{"key":"5059_CR43","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1017\/jns.2013.16","volume":"2","author":"N Hoggard","year":"2013","unstructured":"Hoggard N, Cruickshank M, Moar KM, Bestwick C, Holst JJ, Russell W, et al. A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. J Nutr Sci. 2013;2:e22. https:\/\/doi.org\/10.1017\/jns.2013.16.","journal-title":"J Nutr Sci"},{"issue":"12","key":"5059_CR44","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/j.1464-5491.2008.02588.x","volume":"25","author":"IT Lee","year":"2008","unstructured":"Lee IT, Chan YC, Lin CW, Lee WJ, Sheu WH. Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Diabet Med. 2008;25(12):1473\u20137. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02588.x.","journal-title":"Diabet Med"},{"issue":"4","key":"5059_CR45","first-page":"355","volume":"17","author":"F Shidfar","year":"2012","unstructured":"Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S, Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci. 2012;17(4):355\u201360.","journal-title":"J Res Med Sci"},{"key":"5059_CR46","first-page":"176","volume":"44","author":"P Davoren","year":"2015","unstructured":"Davoren P. Glucose-lowering medicines for type 2 diabetes. Aust J Gen Pract. 2015;44:176\u20139.","journal-title":"Aust J Gen Pract"},{"key":"5059_CR47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijbiomac.2022.03.004","volume":"206","author":"M Shahwan","year":"2022","unstructured":"Shahwan M, Alhumaydhi F, Ashraf GM, Hasan PMZ, Shamsi A. Role of polyphenols in combating Type 2 Diabetes and insulin resistance. Int J Biol Macromol. 2022;206:567\u201379. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.03.004.","journal-title":"Int J Biol Macromol"},{"key":"5059_CR48","doi-asserted-by":"publisher","unstructured":"Ivanovic M, Makoter K, Islamcevic Razborsek M. comparative study of chemical composition and antioxidant activity of essential oils and crude extracts of four characteristic zingiberaceae herbs. Plants (Basel). 2021;10(3). https:\/\/doi.org\/10.3390\/plants10030501.","DOI":"10.3390\/plants10030501"},{"issue":"1","key":"5059_CR49","doi-asserted-by":"publisher","first-page":"10286","DOI":"10.1038\/s41598-024-61011-8","volume":"14","author":"H Gu","year":"2024","unstructured":"Gu H, Zhong L, Zhang Y, Sun J, Liu L, Liu Z. Exploring the mechanism of Jinlida granules against type 2 diabetes mellitus by an integrative pharmacology strategy. Sci Rep. 2024;14(1):10286. https:\/\/doi.org\/10.1038\/s41598-024-61011-8.","journal-title":"Sci Rep"},{"issue":"1","key":"5059_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2016.3771","volume":"50","author":"S Haggblad Sahlberg","year":"2017","unstructured":"Haggblad Sahlberg S, Mortensen AC, Haglof J, Engskog MK, Arvidsson T, Pettersson C, et al. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells. Int J Oncol. 2017;50(1):5\u201314. https:\/\/doi.org\/10.3892\/ijo.2016.3771.","journal-title":"Int J Oncol"},{"issue":"4","key":"5059_CR51","first-page":"655","volume":"10","author":"A Zarghi","year":"2011","unstructured":"Zarghi A, Arfaei S. Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res. 2011;10(4):655\u201383.","journal-title":"Iran J Pharm Res"},{"key":"5059_CR52","unstructured":"National Library of Medicine. CASP3 caspase 3 [Homo sapiens (human)]: 2024 updated May 27, 2024; cited 2024 June 3. https:\/\/www.ncbi.nlm.nih.gov\/gene\/836. Accessed: 3 June."},{"issue":"37","key":"5059_CR53","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1021\/acs.jafc.2c03286","volume":"70","author":"J Chen","year":"2022","unstructured":"Chen J, Meng X. Aronia melanocarpa Anthocyanin Extracts Improve Hepatic Structure and Function in High-Fat Diet-\/Streptozotocin-Induced T2DM Mice. J Agric Food Chem. 2022;70(37):11531\u201343. https:\/\/doi.org\/10.1021\/acs.jafc.2c03286.","journal-title":"J Agric Food Chem"},{"issue":"5","key":"5059_CR54","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1152\/ajpendo.00480.2019","volume":"318","author":"L Zhang","year":"2020","unstructured":"Zhang L, Chen Z, Wang Y, Tweardy DJ, Mitch WE. Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40. Am J Physiol Endocrinol Metab. 2020;318(5):E625\u201335. https:\/\/doi.org\/10.1152\/ajpendo.00480.2019.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5059_CR55","unstructured":"Feingold KR. Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes. Feingold KR AS, Anawalt B, et al., editor. South Dartmouth (MA): Endotext; 2024."},{"issue":"10","key":"5059_CR56","doi-asserted-by":"publisher","first-page":"e10790","DOI":"10.1016\/j.heliyon.2022.e10790","volume":"8","author":"A Prasopthum","year":"2022","unstructured":"Prasopthum A, Insawek T, Pouyfung P. Herbal medicine use in Thai patients with type 2 diabetes mellitus and its association with glycemic control: a cross-sectional evaluation. Heliyon. 2022;8(10):e10790. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10790.","journal-title":"Heliyon"},{"key":"5059_CR57","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.hermed.2024.100889","volume":"46","author":"K Busia","year":"2024","unstructured":"Busia K. Herbal medicine dosage standardisation. J Herb Med. 2024;46:100889. https:\/\/doi.org\/10.1016\/j.hermed.2024.100889.","journal-title":"J Herb Med"},{"key":"5059_CR58","doi-asserted-by":"publisher","unstructured":"Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.01021","DOI":"10.3389\/fphar.2020.01021"},{"key":"5059_CR59","unstructured":"Therapeutic Goods Administration, Australian Government. Medicines containing turmeric or curcumin - risk of liver injury: 2023. https:\/\/www.tga.gov.au\/news\/safety-alerts\/medicines-containing-turmeric-or-curcumin-risk-liver-injury. Accessed: 12 Dec."},{"issue":"4","key":"5059_CR60","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ajhp\/60.4.356","volume":"60","author":"E Basch","year":"2003","unstructured":"Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm. 2003;60(4):356\u20139. https:\/\/doi.org\/10.1093\/ajhp\/60.4.356.","journal-title":"Am J Health Syst Pharm"},{"key":"5059_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.18773\/austprescr.2003.095","volume":"26","author":"GQ Li","year":"2003","unstructured":"Li GQ, Duke CC, Roufogalis BD. The quality and safety of traditional traditional Chinese medicines. Aust Prescr. 2003;26:128\u201330. https:\/\/doi.org\/10.18773\/austprescr.2003.095.","journal-title":"Aust Prescr"},{"key":"5059_CR62","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtcms.2021.11.002","volume":"8","author":"D Ma","year":"2021","unstructured":"Ma D, Wang S, Shi Y, Ni S, Tang M, Xu A. The development of traditional Chinese medicine. J Tradit Chin Med Sci. 2021;8:S1\u20139. https:\/\/doi.org\/10.1016\/j.jtcms.2021.11.002.","journal-title":"J Tradit Chin Med Sci"},{"issue":"3","key":"5059_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaim.2017.09.001","volume":"8","author":"D Shankar","year":"2017","unstructured":"Shankar D, Patwardhan B. AYUSH for New India: vision and strategy. J Ayurveda Integr Med. 2017;8(3):137\u20139. https:\/\/doi.org\/10.1016\/j.jaim.2017.09.001.","journal-title":"J Ayurveda Integr Med"},{"key":"5059_CR64","unstructured":"National Medical Products Administration. China's TCM institutions provide diagnoses, treatment to 1.28 bln people in 2023 Beijing: 2024. https:\/\/english.nmpa.gov.cn\/2024-01\/23\/c_957811.htm#:~:text=BEIJING%20%2D%2D%20Traditional%20Chinese%20medicine,meeting%20that%20opened%20on%20Monday."},{"key":"5059_CR65","doi-asserted-by":"publisher","first-page":"376327","DOI":"10.1155\/2013\/376327","volume":"2013","author":"MM Pandey","year":"2013","unstructured":"Pandey MM, Rastogi S, Rawat AK. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med. 2013;2013:376327. https:\/\/doi.org\/10.1155\/2013\/376327.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"5059_CR66","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/heapol\/czw022","volume":"31","author":"O Oyebode","year":"2016","unstructured":"Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016;31(8):984\u201391. https:\/\/doi.org\/10.1093\/heapol\/czw022.","journal-title":"Health Policy Plan"},{"issue":"5","key":"5059_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7326\/0003-4819-144-5-200603070-00013","volume":"144","author":"JJ Gagnier","year":"2006","unstructured":"Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364\u20137. https:\/\/doi.org\/10.7326\/0003-4819-144-5-200603070-00013.","journal-title":"Ann Intern Med"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05059-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:56:06Z","timestamp":1759229766000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5059"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05059-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CE declares that she is the Jacka Foundation Principal Research Fellow, Chair of the RACGP Integrative Medicine Specific Interest Network (voluntary role), Program Lead of an academic integrative healthcare centre (no financial interest), past GP Advisory Board member for Blackmores Research Institute, has received industry funding from nutraceutical and acupuncture device companies to conduct clinical trials, and has received honoraria and had travel expenses covered for presenting at complementary medicine events. As a medical research institute, NICM Health Research Institute receives research grants and donations from foundations, universities, government agencies, and industry. Sponsors and donors provide untied and tied funding for work to advance the vision and mission of the Institute. AM declares that she is a naturopathic practitioner at a clinic in Sydney, Australia. She is the recipient of a scholarship from the Jacka Foundation of Natural Therapies for her PhD. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}